Elevation Oncology to Present at the SVB Securities Global Biopharma Conference
NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that Joseph Ferra, Interim Chief Executive Officer and Chief Financial Officer of Elevation Oncology, will present at SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 4:20 pm ET. A live webcast and replay of the event will be available on the Events page of the Company's Investor Relations website at https://investors.elevationoncology.com. About Elevation Oncology, Inc. Elevation Oncology Investor and Media Contact View original content to download multimedia:https://www.prnewswire.com/news-releases/elevation-oncology-to-present-at-the-svb-securities-global-biopharma-conference-301741375.html SOURCE Elevation Oncology |
||
Company Codes: NASDAQ-NMS:ELEV |